3 search results
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
UpdatedCochrane EvidencePublished 29 Jun 2017
Drains versus no drains after pelvic lymphadenectomy to prevent lymphocyst formation in women with gynaecological cancer
Background This is an updated version of an original Cochrane review published in Issue 6, 2014. Pelvic lymphadenectomy (removal of lymph glands found in the pelvis) is an important component of the surgical management of gynaecological cancers to see if the cancer has spread. However, it can lead to complications, especially lymphocyst formation (collection ... -
UpdatedCochrane EvidencePublished 23 Jun 2017
Platinum-containing regimens for metastatic breast cancer
What is the issue? Metastatic breast cancer occurs when the cancer has spread to areas of the body beyond the breast and nearby lymph nodes. Although metastatic breast cancer is generally not curable, it is widely accepted that women with metastatic disease should receive some form of chemotherapy to help ease the severity of disease symptoms, while ... -
UpdatedCochrane EvidencePublished 3 Jun 2017
Spectrum of the initial antibiotic treatment for cancer patients with fever and low leucocytes counts
Background: cancer patients develop neutropenia, a decrease in the subset of leucocytes responsible for protection against bacteria, as a result of chemotherapy or cancer. Neutropenia predisposes the patients to severe bacterial infections. Standard antibiotic regimens for cancer patients with neutropenia and fever are directed at most of the bacteria ...
